ClinicalTrials.gg
Drug

Travoprost clinical trials

Also written Travatan and iDose TR.

studies test it
80
open now
2
in phase 3
21
first study started
2000

How each study uses Travoprost is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Travoprost studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
16 Mar 2001 · TRAVATAN · NDA 021257 (FDA, Drugs@FDA)
European Union
27 Nov 2001 · Travatan · EMEA/H/C/000390 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Travoprost
15
TRAVATAN Z®
15
DuoTrav®
10
Travoprost ophthalmic solution 0.004% with SofZia® preservative system (TRAVATAN Z®)
5
Travoprost 0.004% ophthalmic solution
3

Brand

Travatan
12
iDose TR
2

Development codes

PRO 179
1

Other names

OTX-TP
1

In one entry with another drug

Given together, or one or the other

Travoprost/brinzolamide
2

Studies by the year they started

80 studies that test it; most in 2008 (14)

Studies that test Travoprost, by start year
YearStudies
20001
20011
20022
20034
20043
20064
200710
200814
20093
20104
201111
20124
20135
20143
20151
20162
20192
20201
20212
20231
20251
20261

By phase

A phase 1/2 study counts in both.

Phase 1
1
Phase 2
7
Phase 3
21
Phase 4
45
No phase
6

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 62 · Other 18

Alcon Research (47) · Glaukos Corporation (7) · Allergan (4) · Ocular Therapeutix, Inc. (2) · The University of Hong Kong (1) · Pfizer's Upjohn has merged with Mylan to form Viatris Inc. (1) · Université de Sherbrooke (1) · Laboratorios Sophia S.A de C.V. (1)

Often tested with

Tested in the same studies.

Latanoprost (14) · Bimatoprost (11) · Timolol (7) · Brinzolamide (4) · Hypromellose Derivatives (3) · Brimonidine (2) · Dorzolamide (2) · Bimatoprost Ophthalmic Solution (2)

Studies

Open first, then newest update. How each study uses Travoprost is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 80

See all 80 studies that test Travoprost →

Given beside what is tested · 5 — Travoprost is usual care or a partner of the new treatment
As the comparator · 15 — what is tested is compared with Travoprost

Codes

What other systems call Travoprost · ClinicalTrials.gg INT006610

  • MeSH (NLM) D000069557TravoprostConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) WJ68R08KX9TRAVOPROSTConfirmed FDA, NLM, Wikidata
  • RxNorm 283809Confirmed FDA, Wikidata
  • Wikidata Q2193376travoprostConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C47766TravoprostOne source FDA
  • DrugBank DB00287One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.